Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannim Group is a global medicinal cannabis company focused on establishing a reliable supply chain from cultivation to patient. Founded in 2017, the company operates large-scale cultivation facilities in Jamaica and Australia, adhering to GACP and GMP standards. Cannim provides a range of cannabis-based products, including flower and oils, under brands like Lumir and Hummingbud. Their business model emphasizes safety, science, and scale to ensure consistent quality for patients in international markets such as Australia, Germany, and the UK. The company is recognized for its pioneering role in the Jamaican cannabis industry, being among the first to export medical-grade products globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannim.